BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29533868)

  • 1. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
    Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
    Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Broughman JR; Xiong DD; Moeller BJ; Contrera KJ; Prendes BL; Lamarre ED; Ku JA; Burkey BB; Woody NM; Joshi NP; Adelstein DJ; Geiger JL; Frenkel CH; Milas ZL; Brickman DS; Sumrall AL; Carrizosa DR; Greskovich JF; Koyfman SA; Ward MC
    Cancer; 2020 Jun; 126(12):2784-2790. PubMed ID: 32167593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
    Vawda N; Banerjee RN; Debenham BJ
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking impact on HPV driven head and neck cancer's oncological outcomes?
    Mirghani H; Leroy C; Chekourry Y; Casiraghi O; Aupérin A; Tao Y; Nguyen F; Caroline E; Breuskin I; Plana AM; Hartl D; Janot F; Temam S; Gorphe P; Blanchard P
    Oral Oncol; 2018 Jul; 82():131-137. PubMed ID: 29909887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
    Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
    Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
    Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
    Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
    Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P
    Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis.
    Cantrell SC; Reid HH; Li G; Wei Q; Sturgis EM; Ginsberg LE
    J Comput Assist Tomogr; 2014; 38(5):667-73. PubMed ID: 24943254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
    Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
    Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
    Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
    Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
    Mehra R; Ang KK; Burtness B
    Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.
    Granata R; Miceli R; Orlandi E; Perrone F; Cortelazzi B; Franceschini M; Locati LD; Bossi P; Bergamini C; Mirabile A; Mariani L; Olmi P; Scaramellini G; Potepan P; Quattrone P; Ang KK; Licitra L
    Ann Oncol; 2012 Jul; 23(7):1832-7. PubMed ID: 22115925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
    Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.
    Bersani C; Sivars L; Haeggblom L; DiLorenzo S; Mints M; Ährlund-Richter A; Tertipis N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Oncotarget; 2017 May; 8(21):35339-35350. PubMed ID: 28525363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.
    Peck BW; Dahlstrom KR; Gan SJ; Caywood W; Li G; Wei Q; Zafereo ME; Sturgis EM
    Head Neck; 2013 Jun; 35(6):794-9. PubMed ID: 22711172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Lee RH; Salesky M; Benjamin T; El-Sayed IH; George JR; Ha PK; Ryan WR; Heaton CM
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):704-711. PubMed ID: 34182836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review.
    Chen SY; Massa S; Mazul AL; Kallogjeri D; Yaeger L; Jackson RS; Zevallos J; Pipkorn P
    Am J Otolaryngol; 2020; 41(5):102592. PubMed ID: 32521295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.